great to meet you at AAPS PharmSci 360!
During AAPS PharmSci 360 Croda Pharma and Avanti Research highlighted our broad portfolio of excipients, ranging from Super Refined™ high purity excipients through to our expertise in lipid formulation.
Download our posters and presentation below!
POLYSORBATE HYDROLYSIS AND PROTEIN STABILITY: INVESTIGATING THE ROLE OF FREE FATTY ACID PARTICLES
High purity excipients and lipids in enabling advanced drug delivery
IMPROVING INTRANASAL NALOXONE DELIVERY USING EXCIPIENTS IN A TISSUE MODEL
High Purity Excipients and Lipids in Enabling Advanced Drug Delivery
This presentation examines the impact of excipient purity on formulation performance across small molecules, proteins, and nucleic acids. A high-purity dimethyl isosorbide enhances dermal permeation with improved stability in topical small molecule systems. Case studies reveal the role of polysorbate in mitigating surface-induced protein destabilization, and the advantage of high purity surfactants in improving drug stability. Purified surfactants also stabilize RNA-loaded lipid nanoparticles against physical stress by preventing particle leakage and aggregation.
Objectives:
- Understand how excipient purity influences stability along with permeation and bioavailability in topical drug delivery.
- Investigate the impact of surfactant purity on formulation stability and strategies to mitigate enzymatic degradation
- Assess the role of purified surfactants in stabilizing LNP formulations for nucleic acid delivery upon mechanical shaking and freeze-thawing.
Jinghan Li, PhD
Applications Scientist, Croda Pharma
Poster Sessions
About Poster Session One:
Title: IMPROVING iNTRANASAL NALOXONE DELIVERY USING EXCIPIENTS IN A TISSUE MODEL
Poster number: M1330-08-50
Poster presentation: Monday, 1:30pm, Forum 8 on Monitor 50
Your presenter: Dr. Veronica Blanco
About Poster Session Two: